These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33230613)

  • 1. Use of Productivity Loss/Gain in Cost-Effectiveness Analyses for Drugs: A Systematic Review.
    Yuasa A; Yonemoto N; LoPresti M; Ikeda S
    Pharmacoeconomics; 2021 Jan; 39(1):81-97. PubMed ID: 33230613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic Literature Review of the Use of Productivity Losses/Gains in Cost-Effectiveness Analyses of Immune-Mediated Disorders.
    Yuasa A; Yonemoto N; Kamei K; Murofushi T; LoPresti M; Taneja A; Horgan J; Ikeda S
    Adv Ther; 2022 Dec; 39(12):5327-5350. PubMed ID: 36205907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Productivity loss/gain in cost-effectiveness analyses for vaccines: a systematic review.
    Yuasa A; Yonemoto N; LoPresti M; Ikeda S
    Expert Rev Pharmacoecon Outcomes Res; 2021 Apr; 21(2):235-245. PubMed ID: 33593223
    [No Abstract]   [Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Systematic Review of Productivity in Economic Evaluations of Workplace Interventions: A Need for Reporting Criteria?
    Jones C; Verstappen SMM; Payne K
    Appl Health Econ Health Policy; 2019 Oct; 17(5):591-613. PubMed ID: 30937837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Productivity losses associated with cardiovascular disease: a systematic review.
    Gordois AL; Toth PP; Quek RG; Proudfoot EM; Paoli CJ; Gandra SR
    Expert Rev Pharmacoecon Outcomes Res; 2016 Dec; 16(6):759-769. PubMed ID: 27831848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lost productivity in four European countries among patients with rheumatic disorders: are absenteeism and presenteeism transferable?
    Knies S; Candel MJ; Boonen A; Evers SM; Ament AJ; Severens JL
    Pharmacoeconomics; 2012 Sep; 30(9):795-807. PubMed ID: 22670593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Inflammatory Bowel Disease in Canada 2018: Indirect Costs of IBD Care.
    Kuenzig ME; Lee L; El-Matary W; Weizman AV; Benchimol EI; Kaplan GG; Nguyen GC; Bernstein CN; Bitton A; Lee K; Cooke-Lauder J; Murthy SK
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S34-S41. PubMed ID: 31294383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Public sector reforms and their impact on the level of corruption: A systematic review.
    Mugellini G; Della Bella S; Colagrossi M; Isenring GL; Killias M
    Campbell Syst Rev; 2021 Jun; 17(2):e1173. PubMed ID: 37131927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic burden of schizophrenia: empirical analyses from a survey in Thailand.
    Phanthunane P; Whiteford H; Vos T; Bertram M
    J Ment Health Policy Econ; 2012 Mar; 15(1):25-32. PubMed ID: 22611090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recovery schools for improving behavioral and academic outcomes among students in recovery from substance use disorders: a systematic review.
    Hennessy EA; Tanner-Smith EE; Finch AJ; Sathe N; Kugley S
    Campbell Syst Rev; 2018; 14(1):1-86. PubMed ID: 37131375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacoeconomics of influenza vaccination for healthy working adults: reviewing the available evidence.
    Postma MJ; Jansema P; van Genugten ML; Heijnen ML; Jager JC; de Jong-van den Berg LT
    Drugs; 2002; 62(7):1013-24. PubMed ID: 11985488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.
    Ekpu VU; Brown AK
    Tob Use Insights; 2015; 8():1-35. PubMed ID: 26242225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost effectiveness of liraglutide in type II diabetes: a systematic review.
    Zueger PM; Schultz NM; Lee TA
    Pharmacoeconomics; 2014 Nov; 32(11):1079-91. PubMed ID: 25052903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.
    Leaviss J; Davis S; Ren S; Hamilton J; Scope A; Booth A; Sutton A; Parry G; Buszewicz M; Moss-Morris R; White P
    Health Technol Assess; 2020 Sep; 24(46):1-490. PubMed ID: 32975190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The transferability of valuing lost productivity across jurisdictions. differences between national pharmacoeconomic guidelines.
    Knies S; Severens JL; Ament AJ; Evers SM
    Value Health; 2010 Aug; 13(5):519-27. PubMed ID: 20712601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness studies of vertebral augmentation for osteoporotic vertebral fractures: a systematic review.
    Pron G; Hwang M; Smith R; Cheung A; Murphy K
    Spine J; 2022 Aug; 22(8):1356-1371. PubMed ID: 35257838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. For which diseases do broader value elements matter most? An evaluation across 20 ICER evidence reports.
    Shafrin J; Dennen S; Pednekar P; Birch K; Bhor M; Kanter J; Neumann P
    J Manag Care Spec Pharm; 2021 May; 27(5):650-659. PubMed ID: 33779245
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.